查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
靜脈注射用鐵劑的全球市場 - 產業規模，佔有率，趨勢，機會，預測(2018年～2028年):各用途，各產品，各終端用戶，各企業，各地區，預測，機會(2028年)
市場調查報告書
商品編碼
1174499

靜脈注射用鐵劑的全球市場 - 產業規模，佔有率，趨勢，機會，預測(2018年～2028年):各用途，各產品，各終端用戶，各企業，各地區，預測，機會(2028年)

Intravenous Iron Drugs Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Application, By Product, By End-User, By Company, By Region, Forecast & Opportunities, 2028
出版日期: | 出版商: TechSci Research | 英文 118 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球靜脈注射用鐵劑市場在2023年～2027年的預測期間內預計將大幅度成長。

鐵缺乏症的流行和接受透析的慢性腎病患者的激增預計將增加市場增長。

本報告提供全球靜脈注射用鐵劑市場相關調查分析，提供市場規模與預測，各地區預測，競爭情形等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 VOC (客戶的迴響)

第5章 全球靜脈注射用鐵劑市場預測

  • 市場規模與預測
    • 金額和數量
  • 市場佔有率與預測
    • 各用途(腸道吸收不良症候群，發炎性疾病，胃切除/肥胖手術，貧血，Osier-Weber-Rendu 病、血管發育不良、妊娠、其他)
    • 各產品(聚葡萄糖鐵，葡萄糖酸第二鐵，蔗糖鐵，Ferric carboxymaltose，異麥芽糖苷鐵，ferumoxytol)
    • 各終端用戶(醫院·診療所，門診病人照護，居家照護，其他)
    • 各企業(2022年)
    • 各地區
  • 市場地圖

第6章 臨床試驗分析

  • 進行中的臨床試驗
  • 完成的臨床試驗
  • 結束的臨床試驗
  • 開發平台(管線)的明細:各開發階段
  • 開發平台(管線)的明細:各狀態
  • 開發平台(管線)的明細:各研究類型
  • 開發平台(管線)的明細:各國
  • 臨床試驗熱圖

第7章 亞太地區的靜脈注射用鐵劑市場預測

  • 市場規模與預測
    • 金額和數量
  • 市場佔有率與預測
    • 各用途
    • 各產品
    • 各終端用戶
    • 各國
  • 亞太地區:各國分析
    • 中國的靜脈注射用鐵劑市場預測
    • 印度的靜脈注射用鐵劑市場預測
    • 日本的靜脈注射用鐵劑市場預測
    • 韓國的靜脈注射用鐵劑市場預測
    • 澳洲的靜脈注射用鐵劑市場預測

第8章 歐洲的靜脈注射用鐵劑市場預測

  • 市場規模與預測
    • 金額和數量
  • 市場佔有率與預測
    • 各用途
    • 各產品
    • 各終端用戶
    • 各國
  • 歐洲:各國分析
    • 法國的靜脈注射用鐵劑市場預測
    • 德國的靜脈注射用鐵劑市場預測
    • 英國的靜脈注射用鐵劑市場預測
    • 義大利的靜脈注射用鐵劑市場預測

第9章 北美的靜脈注射用鐵劑市場預測

  • 市場規模與預測
    • 金額和數量
  • 市場佔有率與預測
    • 各用途
    • 各產品
    • 各終端用戶
    • 各國
  • 北美:各國分析
    • 美國的靜脈注射用鐵劑市場預測
    • 墨西哥的靜脈注射用鐵劑市場預測
    • 加拿大的靜脈注射用鐵劑市場預測

第10章 南美的靜脈注射用鐵劑市場預測

  • 市場規模與預測
    • 金額和數量
  • 市場佔有率與預測
    • 各用途
    • 各產品
    • 各終端用戶
    • 各國
  • 南美:各國分析
    • 巴西的靜脈注射用鐵劑市場預測
    • 阿根廷的靜脈注射用鐵劑市場預測
    • 哥倫比亞的靜脈注射用鐵劑市場預測

第11章 中東·非洲的靜脈注射用鐵劑市場預測

  • 市場規模與預測
    • 金額和數量
  • 市場佔有率與預測
    • 各用途
    • 各產品
    • 各終端用戶
    • 各國
  • 中東·非洲:各國分析
    • 南非的靜脈注射用鐵劑市場預測
    • 沙烏地阿拉伯的靜脈注射用鐵劑市場預測
    • 阿拉伯聯合大公國的靜脈注射用鐵劑市場預測

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢與發展

第14章 競爭情形

  • 競爭預測
  • 側寫的企業(主要企業)
    • AMAG pharmaceuticals, Inc.
    • Vifor Pharma Management Ltd.
    • Daiichi Sankyo Company, Limited
    • Rockwell Medical Inc.
    • Allergan PLC
    • Pfizer Inc
    • Nippon Shinyaku Co.
    • Novartis International AG
    • Takeda Pharmaceutical Company Limited
    • Bausch Health Companies Inc.

第15章 策略性建議

簡介目錄
Product Code: 5093

Global intravenous iron drugs market is anticipated to grow at a significant rate in the forecast years, 2024-2028. Rising prevalence of iron deficiency coupled with upsurge in chronic renal disease patients undergoing dialysis are projected to augment the growth of intravenous iron drug market. Anemia is the most common blood disorders which is caused due to the iron deficiency. According to the American Society of Hematology, anemia is one of the most common blood disorders in the United States and has affected over 3 million people in the country. Anemia is highly prevalent in pregnant women and can be harmful to baby. According to the Vitamin and Mineral Nutrition Information System (VMNIS) survey, about 40% of mothers and children in developing nations are anemic. Additionally, rising research and development (R&D) activities in intravenous iron, along with rising government funding for the research is expected to propel the growth of the market.

The market of global intravenous iron drugs is segmented into application, product, end-user, company and region. The end-use segment is further fragmented into hospitals & clinics, ambulatory care, homecare, and others. Hospitals & clinics is expected to dominate the market in the coming years as they are the major centers for providing intravenous iron drugs to people. Also, the rising number of people suffering from anemia, or iron deficiency is contributing for the growth of the segment.

Based on regional analysis, North America is the dominant region in 2022. This is attributed to the rise in the number of anemic patients over the past years. Also, the lack of iron deficiency due to lifestyle changes, unhealthy eating choices and others are expected to impel the growth of the segment. On the other hand, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period on account of the rising awareness amongst people regarding chronic diseases such as anemia, etc.

Major players operating in the global intravenous iron drugs market include AMAG pharmaceuticals, Inc., Vifor Pharma Group, Daiichi Sankyo Company, Limited, Sanofi SA, Rockwell Medical Inc., Allergan PLC, Pfizer Inc, Nippon Shinyaku Co., Novartis International AG, Takeda Pharmaceutical Company Limited, and Bausch Health Companies Inc.. The companies tend to adopt various organic and inorganic strategies to sustain in the market of intravenous iron drugs.

Objective of the Study

  • To analyze and estimate the market size of global intravenous iron drugs market from 2018 to 2021.
  • To estimate and forecast the market size of global intravenous iron drugs market from 2022 to 2028 and growth rate until 2028.
  • To classify and forecast global intravenous iron drugs market, the market is categorized on the basis of application, product, end-user, company and region.
  • To identify dominant region or segment in the global intravenous iron drugs market.
  • To identify drivers and challenges for global intravenous iron drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global intravenous iron drugs market.
  • To conduct pricing analysis for global intravenous iron drugs market.
  • To identify and analyze the profile of leading players operating in global intravenous iron drugs market.
  • To identify key sustainable strategies adopted by market players in global intravenous iron drugs market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global intravenous iron drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Intravenous iron drugs key players, suppliers, distributors, and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to intravenous iron drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global intravenous iron drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Intravenous Iron Drugs Market, By Application:

  • Intestinal malabsorption syndromes
  • Inflammatory diseases
  • Gastrectomy/bariatric surgery
  • Anemia
  • Osier-Weber-Rendu disease
  • Angiodysplasia
  • Pregnancy
  • Others

Global Intravenous Iron Drugs Market, By Product:

  • Iron dextran
  • Ferric gluconate
  • Iron sucrose
  • Ferric carboxymaltos
  • Iron isomaltoside 100
  • Ferumoxytol

Global Intravenous Iron Drugs Market, By End-User:

  • Hospitals & Clinics
  • Ambulatory Care
  • Homecare
  • Others

Global Intravenous iron drugs Market, By Region:

  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • North America
    • United States
    • Mexico
    • Canada
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Intravenous iron drugs market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intravenous Iron Drugs Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Intestinal malabsorption syndromes, Inflammatory diseases, Gastrectomy/bariatric surgery, Anemia, Osier-Weber-Rendu disease, Angiodysplasia, Pregnancy, Others)
    • 5.2.2. By Product (Iron dextran, Ferric gluconate, Iron sucrose, Ferric carboxymaltos, Iron isomaltoside 1000, Ferumoxytol)
    • 5.2.3. By End-User (Hospitals & Clinics, Ambugalotry Care, Homecare, Others)
    • 5.2.4. By Company (2022)
    • 5.2.5. By Region
  • 5.3. Market Map

6. Clinical Trial Analysis

  • 6.1. Ongoing Clinical Trials
  • 6.2. Completed Clinical Trials
  • 6.3. Terminated Clinical Trials
  • 6.4. Breakdown of Pipeline, By Development Phase
  • 6.5. Breakdown of Pipeline, By Status
  • 6.6. Breakdown of Pipeline, By Study Type
  • 6.7. Breakdown of Pipeline, By Country
  • 6.8. Clinical Trials Heat Map

7. Asia-Pacific Intravenous Iron Drugs Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Product
    • 7.2.3. By End-User
    • 7.2.4. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Intravenous Iron Drugs Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By End-User
    • 7.3.2. India Intravenous Iron Drugs Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By End-User
    • 7.3.3. Japan Intravenous Iron Drugs Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By End-User
    • 7.3.4. South Korea Intravenous Iron Drugs Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By End-User
    • 7.3.5. Australia Intravenous Iron Drugs Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By End-User

8. Europe Intravenous Iron Drugs Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Product
    • 8.2.3. By End-User
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Intravenous Iron Drugs Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By End-User
    • 8.3.2. Germany Intravenous Iron Drugs Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By End-User
    • 8.3.3. United Kingdom Intravenous Iron Drugs Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By End-User
    • 8.3.4. Italy Intravenous Iron Drugs Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By End-User

9. North America Intravenous Iron Drugs Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Product
    • 9.2.3. By End-User
    • 9.2.4. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Intravenous Iron Drugs Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By End-User
    • 9.3.2. Mexico Intravenous Iron Drugs Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By End-User
    • 9.3.3. Canada Intravenous Iron Drugs Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By End-User

10. South America Intravenous Iron Drugs Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Product
    • 10.2.3. By End-User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Intravenous Iron Drugs Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By End-User
    • 10.3.2. Argentina Intravenous Iron Drugs Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By End-User
    • 10.3.3. Colombia Intravenous Iron Drugs Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By End-User

11. Middle East and Africa Intravenous Iron Drugs Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value & Volume
  • 11.2. Market Share & Forecast
    • 11.2.1. By Application
    • 11.2.2. By Product
    • 11.2.3. By End-User
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Intravenous Iron Drugs Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Application
        • 11.3.1.2.2. By Product
        • 11.3.1.2.3. By End-User
    • 11.3.2. Saudi Arabia Intravenous Iron Drugs Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Application
        • 11.3.2.2.2. By Product
        • 11.3.2.2.3. By End-User
    • 11.3.3. UAE Intravenous Iron Drugs Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Application
        • 11.3.3.2.2. By Product
        • 11.3.3.2.3. By End-User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. AMAG pharmaceuticals, Inc.
    • 14.2.2. Vifor Pharma Management Ltd.
    • 14.2.3. Daiichi Sankyo Company, Limited
    • 14.2.4. Rockwell Medical Inc.
    • 14.2.5. Allergan PLC
    • 14.2.6. Pfizer Inc
    • 14.2.7. Nippon Shinyaku Co.
    • 14.2.8. Novartis International AG
    • 14.2.9. Takeda Pharmaceutical Company Limited
    • 14.2.10. Bausch Health Companies Inc.

15. Strategic Recommendations